Regulatory Status and Use of “Kostaive” (Zapomeran) Vaccine in New Zealand

John Armstrong made this Official Information request to Ministry of Health

The request was successful.

From: John Armstrong

Dear Ministry of Health,

Under the Official Information Act 1982, I request the following information regarding the COVID-19 vaccine known as Kostaive (active substance: zapomeran), developed by CSL Seqirus / Arcturus Therapeutics.

Q1/ Regulatory status
Has Medsafe received any application for approval, provisional consent, or importation of the product known as Kostaive or zapomeran for distribution or administration within New Zealand?

If so, please provide the date the application was received, its current status, and the sponsor name(s).

If no application has been received, please confirm that fact.

Q2/ Administration and distribution
Has Kostaive (or any formulation containing zapomeran) been imported into, distributed, or administered within New Zealand under any authorisation, including provisional consent, clinical trial, compassionate access, or emergency use provisions?

If yes, please provide:

the date(s) and authorisation type(s);

the quantity imported or distributed; and

any associated adverse event reports (in anonymised or aggregate form if appropriate).

Q3/ Clinical trials
Are there any registered or approved clinical trials involving Kostaive or zapomeran currently active or completed in New Zealand?

If so, please provide the trial reference numbers, sponsor names, and trial status, and any associated documentation.

Q4/ Communication and assessment
Please provide any internal Medsafe or Ministry of Health communications, briefing notes, or assessment summaries referencing “Kostaive,” “zapomeran,” or “CSL Seqirus / Arcturus Therapeutics” since 1 January 2023.

Yours faithfully,

John Armstrong

Link to this

From: OIA Requests


Attachment image.png
4K Download


Kia ora John

 

Thank you for your request under the Official Information Act 1982 (the
Act), received by the Ministry of Health on 5 November 2025. You
requested:

 

I request the following information regarding the COVID-19 vaccine known
as Kostaive (active substance: zapomeran), developed by CSL Seqirus /
Arcturus Therapeutics.

Q1/ Regulatory status
Has Medsafe received any application for approval, provisional consent, or
importation of the product known as Kostaive or zapomeran for distribution
or administration within New Zealand?

If so, please provide the date the application was received, its current
status, and the sponsor name(s).

If no application has been received, please confirm that fact.

Q2/ Administration and distribution
Has Kostaive (or any formulation containing zapomeran) been imported into,
distributed, or administered within New Zealand under any authorisation,
including provisional consent, clinical trial, compassionate access, or
emergency use provisions?

If yes, please provide:

the date(s) and authorisation type(s);

the quantity imported or distributed; and

any associated adverse event reports (in anonymised or aggregate form if
appropriate).

Q3/ Clinical trials
Are there any registered or approved clinical trials involving Kostaive or
zapomeran currently active or completed in New Zealand?

If so, please provide the trial reference numbers, sponsor names, and
trial status, and any associated documentation.

Q4/ Communication and assessment
Please provide any internal Medsafe or Ministry of Health communications,
briefing notes, or assessment summaries referencing “Kostaive,”
“zapomeran,” or “CSL Seqirus / Arcturus Therapeutics” since 1 January
2023.

 

The reference number for your request is H2025075039. As required under
the Act, the Ministry will endeavour to respond to your request no later
than 20 working days after the day your request was
received: [1]http://www.ombudsman.parliament.nz/

 

If you have any queries related to this request, please do not hesitate to
get in touch ([2][email address]).

 

 

Ngâ mihi 
 
  

OIA Services Team

Ministry of Health  | Manatû Hauora 

M[3]inistry of Health information releases 

 

show quoted sections

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...

Link to this

From: OIA Requests


Attachment image001.png
8K Download

Attachment image002.png
24K Download

Attachment image003.png
0K Download

Attachment image004.png
0K Download

Attachment image005.png
1K Download

Attachment image006.png
0K Download

Attachment H2025075039 response letter.pdf
160K Download View as HTML


Kia ora John

 

 

 

Please find attached a letter regarding your request for official
information. If you wish to discuss any aspect of your request with us,
including this decision, please feel free to contact the OIA Services Team
on [1][email address].

 

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [2][email address] or by calling 0800
802 602.

 

 

Ngā mihi

 

OIA Services Team

[3]Manatū Hauora information releases

 
[4][IMG] [5][IMG] [6][IMG] [7][IMG]

 

 

 

show quoted sections

References

Visible links
1. mailto:[email address]
2. mailto:[email address]
3. https://www.health.govt.nz/about-ministr...
4. https://www.facebook.com/minhealthnz/
5. https://twitter.com/minhealthnz
6. https://www.youtube.com/minhealthnz
7. https://www.linkedin.com/company/ministr...

Link to this

Things to do with this request

Anyone:
Ministry of Health only: